当前位置:首页 - 行情中心 - 昭衍新药(603127) - 财务分析

昭衍新药

(603127)

  

流通市值:238.70亿  总市值:283.75亿
流通股本:6.30亿   总股本:7.49亿

昭衍新药(603127)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.61亿元,每股收益0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益810506.65万元,未分配利润213351.62万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产947346.23万元,负债136839.58万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入668,575,211.14287,337,235.012,018,333,771.811,335,156,050.4
营业总成本667,394,336.77288,252,886.211,763,748,341.311,227,734,251.03
其他经营收益
营业利润79,855,509.3649,382,588.17104,347,309.12-69,661,013.72
利润总额80,119,573.7549,383,749.8104,039,073.62-69,892,269.79
净利润60,932,376.3841,119,465.2569,755,063.9-74,244,009.94
每股收益
其他综合收益-2,334,068.82-766,939.36-51,041,084.41-4,859,185.75
综合收益总额58,598,307.5640,352,525.8918,713,979.49-79,103,195.69
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计5,279,952,786.465,063,761,087.585,031,197,927.385,334,112,028.96
非流动资产:
非流动资产合计4,193,509,475.844,360,897,521.944,364,954,683.074,191,072,779.02
资产总计9,473,462,262.39,424,658,609.529,396,152,610.459,525,184,807.98
流动负债:
流动负债合计1,167,148,440.511,097,659,363.431,110,568,596.281,298,706,870.56
非流动负债:
非流动负债合计201,247,346.06217,793,323.03206,395,760.21235,643,339.19
负债合计1,368,395,786.571,315,452,686.461,316,964,356.491,534,350,209.75
所有者权益(或股东权益):
归属于母公司股东权益合计8,104,696,831.488,108,836,282.88,078,818,586.728,002,435,682.2
股东权益合计8,105,066,475.738,109,205,923.068,079,188,253.967,990,834,598.23
负债和股东权益合计9,473,462,262.39,424,658,609.529,396,152,610.459,525,184,807.98
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计875,978,571.86429,804,957.521,811,387,046.151,367,691,390.73
经营活动现金流出小计713,205,577.03364,655,756.361,472,458,327.751,175,365,681.39
经营活动产生的现金流量净额162,772,994.8365,149,201.16338,928,718.4192,325,709.34
投资活动产生的现金流量:
投资活动现金流入小计1,038,476,224.2617,613,712.483,365,501,966.772,508,098,115.21
投资活动现金流出小计1,473,488,544.15951,573,490.955,328,525,952.313,458,148,881.92
投资活动产生的现金流量净额-435,012,319.95-333,959,778.47-1,963,023,985.54-950,050,766.71
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计28,180,254.5718,665,128.1265,627,486.97248,828,091.97
筹资活动产生的现金流量净额-28,180,254.57-18,665,128.1-265,627,486.97-248,828,091.97
汇率变动对现金及现金等价物的影响-2,551,375.3-1,154,223.861,278,854.73-6,969,366.76
现金及现金等价物净增加额-302,970,954.99-288,629,929.27-1,888,443,899.38-1,013,522,516.1
期末现金及现金等价物余额662,232,173.6676,571,156.45965,203,128.591,840,124,511.87
补充资料:
现金及现金等价物的净增加额-302,970,954.99--1,888,443,899.38-
最新报告期:2025-08-29
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华西证券崔文亮,徐顺利0.210.210.212025-08-29
中金公司张琎,吴婉桦0.520.54--2025-08-28
中信证券陈竹,韩世通0.520.560.622025-07-01
TOP↑